ACADIA Pharmaceuticals, Inc. (ACAD)
20.74
+0.02
(+0.10%)
USD |
NASDAQ |
Mar 20, 16:00
20.72
-0.02
(-0.07%)
After-Hours: 20:00
ACADIA Pharmaceuticals Shareholders Equity (Quarterly) : 1.227B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 738.98M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Marker Therapeutics, Inc. | 16.80M |
| Agilent Technologies, Inc. | 6.908B |
| Axsome Therapeutics, Inc. | 88.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.564B |
| Total Liabilities (Quarterly) | 336.80M |
| Debt to Equity Ratio | 0.0425 |
| Current Ratio | 3.833 |
| Net Debt Paydown Yield | -0.01% |